# Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects

> **NCT06171048** · PHASE1 · UNKNOWN · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 236 (estimated)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** CM310

## Key facts

- **NCT ID:** NCT06171048
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-30
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 236 (ESTIMATED)
- **Last updated:** 2023-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06171048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06171048, "Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06171048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*